3EULAIO A, HUNTZINGER E. Getting to the root of miRNA-mediated gene silencing[ J]. Cell ,2008,132 ( 1 ) :9-14.
4FRIEDMAN RC, FARH KK, BURGE CB, et al. Most mammalian mR- NAs are conserved targets of microRNAs [J]. Genome Res, 2009,19 (1) :92-105.
5ZHAO, Y, SAMAL E, SRIVASTAVA D. Serum response factor regulates a muscle- specific microRNA that targets Hand2 during cardiogenesis[J]. Nature,2005,436(7048) :214-220.
6HARRIS TA, YAMAKUCHI M, FERLITO Met al. Lowenstein, MicroRNA-126 regulates endothelial expression of vascular cell adhesion nlolecule 1 [ J]. Proceedings of the National Academy of Sciences of the United States of America,2008,105 (5) : 1516-1521.
7MERKEROVA M, BELICKOVA M, BRUCHOVA H. Differential expression of microRNAs in hematopoietic cell lineages [ J ]. European Journal of Haematology,2008,81 (4) :304-310.
8SCHMIDT M, PAES K, De MAZIERE A, et al. EGFL7 regulates the collective migration of endothelial cells by restricting their spatial dis- tribution [ J ]. Development,2007,134 ( 16 ) :2913- 2923.
9FISH JE, SANTORO MM, MORTON SU, et al. miR- 126 regulates an- giogenic signaling and vascular integrity [ J ]. Developmental Cell, 2008,15 (2) :272- 284.
10WANG S, AURORA AB, JOHNSON BA, et al. The endothelial specif- ic MicroRNA miR-126 governs vascular integrity andangiogenesis [ J]. Developmental Cell ,2008,15 (2) :261-271.
二级参考文献21
1Lawrie CH, Soneji S, Marafioti T, et al. MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. Int J Cancer, 2007, 121 : 1156-1161.
2Lawrie CH, Gal S, Dunlop HM, et al. Detection of elevated levels of tumour-associated mieroRNAs in serum of patients with diffuse 1TTge B-cell lyphoma. BrJ Haem.atol, 2008, 1141-672-675.
3Han's CP, Weiseuberger D, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by im- munohistochemistry using a tissue microarry. Blood, 2003, 103: 275 -282.
4van Imhoff GW, Boerma E J, van der Halt B, et al. Prognostic im- pact of germinal center-associated proteins and chromosomal break- points in poor-risk diffuse large B-cell lymphoma. J Clin Oncol, 2006, 24:4135-4142.
5Gustaaf W, Van Imhoff, Evert-Jan G, et al. Prognostic impact of germinal center-associated proteins and chromosomal breakpoints in poor-risk diffuse large B-cell lymphoma. Clin Oncol, 2006, 24: 4135-4142.
6Alencer AJ, Malumbres R, Kozloski GA, et al. McroRNAs are in- dependent priditors of outcome in diffuse large B-cell lymphoma patients treated with R-CHOP. Clin Cancer Res, 2011, 17:4125- 4135.
7Hunt KE, Reichard KK. Diffuse large B-cell lymphoma. Arch- pathol Lab Med, 2008, 132 : 118-124.
9Lawrie CH. MicroRNAs and haematology: small molecules, big function. Br J Haematol, 2007, 137:503-512.
10Habermann TM, Weller EA, Morrison VA, et al. Rituximab- CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma. J Clin Oncol, 2006, 24:3121-5127.
